Skip to main navigation Skip to search Skip to main content

Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium

  • The ABCTB Investigators
  • , The NBCS Collaborators
  • Antoni van Leeuwenhoek Hospital
  • German Cancer Research Center
  • National Cancer Institute (NCI)
  • University of California, Irvine
  • Lund University
  • University of Eastern Finland
  • University of Hamburg
  • Charité – Universitätsmedizin Berlin
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Helsinki University Hospital
  • Örebro University
  • Copenhagen University Hospital – Herlev and Gentofte
  • University of Copenhagen
  • University of Cambridge
  • Universidad de la Sabana
  • University of Tübingen
  • University of Utah School of Medicine
  • University of Pisa
  • Instituto de Investigacion Sanitaria Galicia Sur (IISGS)
  • Seoul National University
  • Seoul National University Cancer Research Institute
  • University of Sydney
  • Mayo Clinic Rochester, MN
  • University of Sheffield
  • Karolinska Institutet
  • Hannover Medical School
  • University of Westminster
  • University of Southampton, Faculty of Medicine
  • H. Lee Moffitt Cancer Center & Research Institute
  • University of Manchester
  • Manchester University NHS Foundation Trust
  • University of California at Los Angeles
  • University of Santiago de Compostela
  • Moores Cancer Center
  • American Cancer Society
  • Hospital Clínico San Carlos de Madrid
  • Cancer Council Victoria
  • Melbourne School of Population and Global Health
  • Monash University
  • University of Oulu
  • APHP – Paris Saclay University
  • Keck School of Medicine of USC
  • University Hospitals Leuven
  • National University of Singapore
  • MOH Holdings Pte Ltd.
  • University of Western Australia
  • Robert Bosch Foundation
  • University of Oxford
  • Harvard University
  • Aichi Cancer Center Hospital and Research Institute
  • Nagoya University
  • Erasmus MC Cancer Institute
  • MASA
  • Pomeranian Medical University in Szczecin
  • Ulm University
  • Heidelberg University 
  • Oslo University Hospital
  • University of Oslo
  • Beckman Research Institute of City of Hope
  • VIB Department of Molecular Microbiology
  • KU Leuven
  • University of Hawai'i at Mānoa
  • Genome Institute of Singapore
  • Karolinska University Hospital
  • Cancer Research Malaysia
  • University of Nottingham Malaysia
  • Heraklion University Hospital
  • University of North Carolina at Chapel Hill
  • Guy’s Hospital
  • Shaukat Khanum Memorial Cancer Hospital and Research Centre
  • Lady Davis Carmel Medical Center
  • Hospital Puerta de Hierro
  • University Hospital of Larissa
  • King's College London
  • Academia Sinica - Institute of Biomedical Sciences
  • China Medical University Taichung
  • Vanderbilt University
  • University of Melbourne
  • Cornell University
  • Leiden University
  • University of Birmingham
  • Northern Finland Laboratory Centre Oulu
  • Uppsala University
  • Armed Forces Capital Hospital
  • Tri-Service General Hospital
  • University of Malaya

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

Background: It is not known whether modifiable lifestyle factors that predict survival after invasive breast cancer differ by subtype. Methods: We analyzed data for 121,435 women diagnosed with breast cancer from 67 studies in the Breast Cancer Association Consortium with 16,890 deaths (8,554 breast cancer specific) over 10 years. Cox regression was used to estimate associations between risk factors and 10-year all-cause mortality and breast cancer. specific mortality overall, by estrogen receptor (ER) status, and by intrinsic-like subtype. Results: There was no evidence of heterogeneous associations between risk factors and mortality by subtype (Padj > 0.30). The strongest associations were between all-cause mortality and BMI ≥30 versus 18.5.25 kg/m2 [HR (95% confidence interval (CI), 1.19 (1.06-1.34)]; current versus never smoking [1.37 (1.27-1.47)], high versus low physical activity [0.43 (0.21-0.86)], age ≥30 years versus <20 years at first pregnancy [0.79 (0.72-0.86)]; >0.<5 years versus ≥10 years since last full-term birth [1.31 (1.11-1.55)]; ever versus never use of oral contraceptives [0.91 (0.87-0.96)]; ever versus never use of menopausal hormone therapy, including current estrogen.progestin therapy [0.61 (0.54.0.69)]. Similar associations with breast cancer mortality were weaker; for example, 1.11 (1.02-1.21) for current versus never smoking. Conclusions: We confirm associations between modifiable lifestyle factors and 10-year all-cause mortality. There was no strong evidence that associations differed by ER status or intrinsic-like subtype. Impact: Given the large dataset and lack of evidence that associations between modifiable risk factors and 10-year mortality differed by subtype, these associations could be cautiously used in prognostication models to inform patient-centered care.

Original languageEnglish
Pages (from-to)623-642
Number of pages20
JournalCancer Epidemiology Biomarkers and Prevention
Volume30
Issue number4
DOIs
StatePublished - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Breast cancer risk factors and survival by tumor subtype: Pooled analyses from the breast cancer association consortium'. Together they form a unique fingerprint.

Cite this